Novo Nordisk to stop once-weekly injectable semaglutide kidney outcomes trial Ruchika Sharma10 Oct 2023 11:00 AM IST"Based on the decision to stop the trial at interim, the process of closing the trial will be initiated. To protect the integrity of the trial, Novo...
Novo Nordisk India head eyes 2026 weight-loss drug Wegovy launch Roshni Dhar3 Oct 2023 3:24 PM ISTDanish drugmaker Novo Nordisk aims to bring its blockbuster weight-loss drug Wegovy to India in 2026, after securing regulatory approvals and ensuring...
FDA approve Nedosiran Injection for rare kidney disorder Dr. Kamal Kant Kohli3 Oct 2023 2:00 PM ISTThe US Food and Drug Administration has approved Nedosiran (Rivfloza), a once-monthly RNA interference (RNAi) injection for certain patients with...
Novo Nordisk gets USFDA nod for Rivfloza injection for rare genetic condition Ruchika Sharma3 Oct 2023 11:49 AM ISTRivfloza, the RNAi therapeutic by Novo Nordisk, was developed using the proprietary GalXC RNAi technology platform.
Health Bulletin 2/ October/ 2023 Roshni Dhar2 Oct 2023 3:40 PM ISTHere are the top health stories for the day:MCC releases final result for round 3 of NEET PG, NEET MDS counsellingThe Medical Counselling Committee...
Novo Nordisk eyes to bring blockbuster weight-loss drug Wegovy to India in 2026 Ruchika Sharma1 Oct 2023 1:00 PM ISTNovo charges more than $1300 in the U.S. for a monthly supply and about 300 euros ($317) a month in Germany.
Anti obesity drugs can shrink more than patients Roshni Dhar25 Sept 2023 2:48 PM ISTStarry-eyed venture capitalists love to talk about how promising startups might capture a chunk of a giant total addressable market (TAM). This...
USFDA says timeline for supply limits on Novo Nordisk weight loss drug Wegovy unclear Ruchika Sharma13 Sept 2023 2:30 PM ISTThe U.S. Food and Drug Administration has said it was not clear when supply of lower doses of Novo Nordisk's Wegovy would normalize, backtracking from...
Novo Nordisk unveils weight loss injection Wegovy in Britain Ruchika Sharma4 Sept 2023 2:30 PM ISTLondon: Novo Nordisk launched its weight-loss injection Wegovy in Britain on Monday, its second debut in Europe in just over a month as the drugmaker...
Novo Nordisk briefly overtakes LVMH as Europe most valuable company Ruchika Sharma4 Sept 2023 12:30 PM ISTLondon: Danish drugmaker Novo Nordisk unseated LVMH as Europe's most valuable listed company on Friday, ending the French luxury group's...
Novo Nordisk to acquire Inversago Pharma for up to USD 1.075 billion Ruchika Sharma13 Aug 2023 3:30 PM ISTThe closing of the acquisition is subject to receipt of applicable regulatory approvals and other customary conditions and is expected to happen...
Semaglutide may reduce MACE among overweight patients with CVD Dr. Kamal Kant Kohli10 Aug 2023 10:30 AM ISTBagsværd: According to topline data from the SELECT study, Compared with placebo injectable semaglutide 2.4 mg reduced risk for major adverse CV...
